Yicheng Liu

Yicheng (Alex) Liu is a Clinical Trial Manager at Arcus Biosciences since April 2023, previously serving as a Clinical Study Manager at Reata Pharmaceuticals from September 2018 to March 2023, where involvement included a global Phase III pivotal clinical trial with an enrollment target of approximately 850 participants. Prior experience includes roles as an Associate Clinical Study Manager and Clinical Trial Associate at Reata, contributing to the CARDINAL Phase II-III study. Yicheng also worked as a Clinical Research Associate at AROG Pharmaceuticals and DAVA CRO for 2.5 years, specializing in oncology clinical research. Earlier positions include a Research Fellow at the University of Minnesota and a Research Associate at Texas A&M University focused on renewable energy and metabolic engineering. Yicheng's career began as a Teacher in Biological Science at New Taipei Municipal An Kang High School. Academic qualifications include a Master's degree in Biotechnology from Texas A&M University and a Bachelor of Science in Life Science from National Taiwan Normal University.